Artiva Biotherapeutics, Inc. (ARTV) SEC filings
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.86−0.10 (-2.53%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
SEC filings
36 of Artiva Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Nov 11, 2026 | Nov 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 9, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2026 | Oct 27, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 8, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2026 | Jul 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 19, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2025 | Jun 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2025 | Apr 29, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2025 | Jan 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2024 | Oct 22, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 29, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2024 | Aug 29, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2024 | Jul 22, 2024 | SEC EDGAR |
See a number that looks wrong?